Madrigal Pharmaceuticals, Inc. logo MDGL - Madrigal Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 20
HOLD 2
SELL 1
STRONG
SELL
0
| PRICE TARGET: $731.25 DETAILS
HIGH: $964.00
LOW: $571.00
MEDIAN: $679.00
CONSENSUS: $731.25
UPSIDE: 41.37%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001
Revenue
Revenue 958.4 180.1 0 0 0 0 0 0 0 0 0 0 0 0 7.6 14.8 144.2 2.6 0.7 0 0 0.2 1.3 0 0
Cost of Revenue 56.1 6.2 0 0 0 0.5 0.1 0.1 0.1 0.0 0 0.7 0.5 0.7 1.5 0 0 0 0 3.7 0 3.1 0 0 0
Gross Profit 902.3 173.9 0 0 0 (0.5) (0.1) (0.1) (0.1) (0.0) 0 (0.7) (0.5) (0.7) 6.1 0 0 0 0 (3.7) 0 (3.0) 1.3 0 0
Operating Expenses
R&D Expenses 388.5 236.7 272.4 245.4 205.2 184.8 72.3 25.4 24.4 15.9 54.2 68.2 71.9 49.4 41.5 40.3 51.1 81.6 52.0 50.5 59.9 38.1 24.3 7.3 0.3
SG&A Expenses 813.8 435.1 108.1 48.1 37.3 21.9 22.6 15.0 7.7 9.3 13.4 15.7 15.7 11.7 11.6 11.4 12.7 14.7 14.9 8.6 11.3 7.4 5.3 0 0.1
Other Expenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 1,202.4 671.8 380.5 293.6 242.5 205.8 94.9 40.4 31.8 25.0 3.2 83.3 87.0 60.4 51.6 49.8 61.2 96.1 63.6 55.5 68.7 44.0 29.6 7.3 0.4
Operating Income
Operating Income (300.1) (497.9) (380.5) (293.6) (242.5) (206.3) (95.0) (40.5) (31.9) (25.0) (3.2) (84.0) (87.6) (61.1) (45.4) (36.9) 80.5 (93.7) (66.2) (59.2) (71.2) (45.3) (28.3) (36.3) (0.4)
Interest Expense 22.3 14.7 12.7 4.0 0 0 0 0 0 1.2 1.1 2.2 2.6 1.8 1.9 0.6 0.3 0.5 0 0 0 0 0 0 0
Interest Income 37.4 46.7 19.6 2.2 0.4 4.3 11.0 7.7 0.6 0.0 0 0 0 0 0 0 0.1 1.6 2.7 1.9 2.3 1.0 0 0 0
Profitability
EBITDA (264.5) (450.1) (360.4) (290.9) (241.4) (201.8) (83.8) (32.7) (31.1) (25.2) (3.2) (83.3) (87.0) (60.2) (44.0) (35.0) 81.9 (89.4) (60.1) (53.6) (66.4) (44.4) (27.3) 10.8 (0.4)
EBIT (266.0) (451.2) (360.9) (291.4) (241.8) (202.2) (83.9) (32.8) (31.2) (25.2) (3.2) (84.0) (87.6) (60.9) (45.4) (36.9) 79.4 (92.1) (63.5) (57.3) (68.9) (45.9) (28.3) (36.3) 0
Income Before Tax (288.3) (465.9) (373.6) (295.4) (241.8) (202.2) (83.9) (32.8) (31.2) (26.4) (68.7) (86.2) (90.2) (62.8) (47.4) (37.5) 79.1 (92.6) (63.5) (59.1) (68.9) (45.9) (27.9) (54.4) 0
Income Tax Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (18.2) 0.4
Net Income (288.3) (465.9) (373.6) (295.4) (241.8) (202.2) (83.9) (32.8) (31.2) (26.4) (6.8) (86.2) (90.2) (62.8) (47.4) (37.5) 79.1 (92.6) (63.5) (57.3) (68.9) (45.9) (27.9) (36.2) (0.4)
Per Share Data
EPS (Basic) -12.85 -21.90 -19.99 -17.23 -14.63 -13.09 -4.73 -2.22 -2.54 -5.07 -401.56 -30.62 -44.48 -36.99 -35.14 -32.49 81.55 -96.09 -68.45 -90.03 -108.31 -85.96 -44.65 -105.09 -4.55
EPS (Diluted) -12.85 -21.90 -19.99 -17.23 -14.63 -13.09 -4.73 -2.22 -2.54 -5.07 -401.56 -30.62 -44.48 -36.99 -35.14 -32.49 81.20 -96.09 -68.45 -90.03 -108.31 -85.96 -44.65 -105.09 -4.55
Shares Outstanding 22.4 21.3 18.7 17.1 16.5 15.4 15.4 14.8 12.2 5.2 0.2 2.8 2.0 1.7 1.3 1.2 1.0 1.0 0.9 0.6 0.6 0.5 0.6 0.3 0.1
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008 2004 2003 2001
Current Assets
Cash & Cash Equivalents 198.7 100.0 99.9 331.5 36.3 54.0 46.7 57.4 148.6 40.5 44.2 52.0 42.7 36.1 0
Short-Term Investments 784.9 826.2 534.2 27.2 234.1 230.1 392.3 426.3 42.9 0 0 21.5 82.2 40.2 0
Net Receivables 134.5 53.8 0 0 0 0 0 0 0 0 0 16 0 0 0
Inventory 74.8 34.1 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 52.9 18.8 3.1 2.6 0 0 1.2 1.5 0.5 0 0.4 0.2 0.5 0.3 0
Total Current Assets 1,245.8 1,032.9 637.3 361.4 271.7 285.2 440.2 485.2 192.0 41.2 44.6 91.2 126.0 77.1 0
Non-Current Assets
Property, Plant & Equipment 6.4 4.6 3.3 1.2 1.6 1.8 1.9 0.2 0.3 0.0 4.0 5.9 4.8 3.2 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 7.4 4.7 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0 0 0 0 0 0 0.4 0.1 1.2 0.1 0
Total Non-Current Assets 13.8 9.3 3.3 1.2 1.6 1.8 1.9 0.2 0.3 0.0 4.3 6.0 6.0 3.3 0
Total Assets 1,259.6 1,042.2 640.5 362.6 273.3 287.0 442.1 485.4 192.3 41.2 48.9 97.3 132.0 80.4 2.8
Current Liabilities
Account Payables 48.9 43.6 28.0 23.8 21.4 1.0 1.2 2.5 1.9 0.8 4.0 3.3 2.9 0.2 0
Short-Term Debt 1.0 0 0 0 0 0 0 0 0 0 0 2.2 0.5 0 0
Deferred Revenue 0 0 0 0 0 0 0 0 0 0 4.6 12.6 0.5 0.3 0
Other Current Liabilities 260.4 35.0 17.0 14.9 6.8 4.7 2.8 1.8 0 0 3.8 12.3 8.3 0 0
Total Current Liabilities 310.3 169.3 118.5 115.9 76.8 46.6 25.1 8.4 10.1 4.8 16.5 33.3 12.9 3.5 0
Non-Current Liabilities
Long-Term Debt 346.6 117.6 115.5 49.3 0 0 0 0 0 0 0 6.3 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 (0.8) (114.4) 0 0 0
Other Non-Current Liabilities (6.7) 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Non-Current Liabilities 346.6 118.6 116.7 49.3 0.4 0.5 0.4 0 0 0 7.5 122.7 1.2 0 0
Total Liabilities 656.9 287.9 235.2 165.2 77.2 47.0 25.5 8.4 10.1 4.8 24.0 156.0 14.1 3.5 0.0
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (2,090.5) (1,802.2) (1,336.3) (962.7) (667.3) (425.5) (223.2) (139.3) (106.5) (75.3) (313.6) (392.7) (110.4) (64.5) 0
Accumulated Other Comprehensive Income 0.9 0.5 0.5 (0.0) (0.1) 0.0 0.2 (0.3) (0.0) 0.0 (16.0) 0.0 (10.6) (2.8) 0
Total Stockholders' Equity 602.7 754.4 405.3 197.4 196.1 240.0 416.6 477.0 182.3 36.4 24.9 (58.8) 118.0 76.9 2.7
Total Liabilities & Equity 1,259.6 1,042.2 640.5 362.6 273.3 287.0 442.1 485.4 192.3 41.2 48.9 97.3 132.0 80.4 2.8
Debt Metrics
Total Debt 354.4 119.6 117.2 49.9 0.8 0.8 0.7 0 0 0 2.1 10.5 1.7 0 0
Net Debt 155.7 19.6 17.3 (281.7) (35.5) (53.2) (46.0) (483.7) (191.5) (40.5) (42.1) (41.6) (41.0) (36.1) 0
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2005 2004 2003
Operating Activities
Net Income (288.3) (465.9) (373.6) (295.4) (241.8) (202.2) (83.9) (32.8) (31.2) (26.4) (68.9) (45.9) (27.9)
Depreciation & Amortization 4.7 0.7 0.5 0.5 0.4 0.5 0.1 0.1 0.1 0.0 2.5 1.5 1.0
Stock-Based Compensation 98.1 79.9 49.7 31.6 26.9 20.7 22.8 13.5 3.3 8.7 0 0 0
Change in Working Capital (8.5) (72.3) (3.3) 37.6 30.7 23.5 19.5 (6.3) 5.5 (1.1) 0.3 7.4 0.9
Other Non-Cash Items 4.4 2.1 2.4 0.8 7.3 21.8 0 13.1 2.5 1.2 4.3 3.2 2.4
Operating Cash Flow (189.6) (455.6) (324.2) (224.9) (183.9) (157.6) (41.6) (25.5) (22.3) (17.6) (61.9) (33.8) (23.6)
Investing Activities
Capital Expenditure (0.5) (1.5) (1.5) (0.2) (0.2) (0.3) (0.2) (0.0) (0.1) (0.0) (4.9) (1.6) (0.8)
Acquisitions 0 0 0 (0.0) 0.8 1.9 0 (3.7) 0 5.8 0 0 0
Purchases of Investments (1,047.5) (1,131.2) (834.4) (143.5) (394.1) (329.3) (619.3) (614.4) (70.2) (10.7) (184.4) (124.7) (47.9)
Sales/Maturities of Investments 1,089.3 839.2 333.4 350.4 389.3 489.5 650.2 234.3 48.3 26.1 228.4 82.5 7.8
Other Investing Activities (9.0) 19.1 0 0.0 (0.8) (1.9) 0 3.7 (0.0) 0.8 0 0 0.5
Investing Cash Flow 32.3 (274.4) (502.5) 206.7 (5.1) 159.8 30.7 (380.1) (22.0) 22.0 39.2 (43.8) (40.4)
Financing Activities
Net Debt Issuance 217.9 0 65 50 0 0 0 0 0 8.5 (1.1) (0.2) (0.1)
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 337.6 269.9 8.1 1.0 0.7 0.2 2.5 0 (0.0) 4.7 1.1 0
Financing Cash Flow 256.0 735.1 595.1 313.5 171.2 5.1 0.2 314.3 173.8 14.5 3.8 84.3 71.1
Cash Position
Net Change in Cash 98.8 5.1 (231.6) 295.3 (17.7) 7.3 (10.7) (91.2) 129.5 18.8 (18.9) 6.7 7.1
Cash at Beginning 105.0 99.9 331.5 36.3 54.0 46.7 57.4 148.6 19.1 0.3 42.7 36.1 29.0
Cash at End 203.8 105.0 99.9 331.5 36.3 54.0 46.7 57.4 148.6 19.1 23.8 42.7 36.1
Free Cash Flow (190.0) (457.0) (325.7) (225.1) (184.1) (157.9) (41.8) (25.5) (22.4) (17.6) (66.8) (35.4) (24.4)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001
Income Statement
Revenue 958.4 180.1 0 0 0 0 0 0 0 0 0 0 0 0 7.6 14.8 144.2 2.6 0.7 0 0 0.2 1.3 0 0
Gross Profit 902.3 173.9 0 0 0 (0.5) (0.1) (0.1) (0.1) (0.0) 0 (0.7) (0.5) (0.7) 6.1 0 0 0 0 (3.7) 0 (3.0) 1.3 0 0
Operating Income (300.1) (497.9) (380.5) (293.6) (242.5) (206.3) (95.0) (40.5) (31.9) (25.0) (3.2) (84.0) (87.6) (61.1) (45.4) (36.9) 80.5 (93.7) (66.2) (59.2) (71.2) (45.3) (28.3) (36.3) (0.4)
Net Income (288.3) (465.9) (373.6) (295.4) (241.8) (202.2) (83.9) (32.8) (31.2) (26.4) (6.8) (86.2) (90.2) (62.8) (47.4) (37.5) 79.1 (92.6) (63.5) (57.3) (68.9) (45.9) (27.9) (36.2) (0.4)
EPS (Diluted) -12.85 -21.90 -19.99 -17.23 -14.63 -13.09 -4.73 -2.22 -2.54 -5.07 -401.56 -30.62 -44.48 -36.99 -35.14 -32.49 81.20 -96.09 -68.45 -90.03 -108.31 -85.96 -44.65 -105.09 -4.55
Balance Sheet
Cash & Equivalents 198.7 100.0 99.9 331.5 36.3 54.0 46.7 57.4 148.6 40.5 44.2 52.0 42.7 36.1 0
Total Assets 1,259.6 1,042.2 640.5 362.6 273.3 287.0 442.1 485.4 192.3 41.2 48.9 97.3 132.0 80.4 2.8
Total Debt 354.4 119.6 117.2 49.9 0.8 0.8 0.7 0 0 0 2.1 10.5 1.7 0 0
Stockholders' Equity 602.7 754.4 405.3 197.4 196.1 240.0 416.6 477.0 182.3 36.4 24.9 (58.8) 118.0 76.9 2.7
Cash Flow
Operating Cash Flow (189.6) (455.6) (324.2) (224.9) (183.9) (157.6) (41.6) (25.5) (22.3) (17.6) (61.9) (33.8) (23.6)
Capital Expenditure (0.5) (1.5) (1.5) (0.2) (0.2) (0.3) (0.2) (0.0) (0.1) (0.0) (4.9) (1.6) (0.8)
Free Cash Flow (190.0) (457.0) (325.7) (225.1) (184.1) (157.9) (41.8) (25.5) (22.4) (17.6) (66.8) (35.4) (24.4)